The Food and Drug Administration (FDA) is announcing that a collection of information entitled, ``Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Document
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic
The Food and Drug Administration (FDA) is announcing that a collection of information entitled, ``Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Prod...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 30689
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic,” thefederalregister.org (May 29, 2015), https://thefederalregister.org/documents/2015-12977/agency-information-collection-activities-announcement-of-office-of-management-and-budget-approval-guidance-for-industry-.